Medical supervision required

DHH-B Side Effects

DHH-B (Dihydrohonokiol-B) is a potent honokiol analogue studied for anxiolytic and neuroprotective effects. It is generally well tolerated at therapeutic doses and has a benzodiazepine-like mechanism without the dependency profile.

Generally well tolerated Medically reviewed by Dr. Ploy Pitayanon, MD

This page is for educational purposes only and is not medical advice. Side effects vary between individuals. All protocols at Peptides Thailand are individually prescribed by licensed physicians. Contact your doctor with any concerns during treatment.

Side effects to be aware of

Mild sedation

Common

Sedation is expected and is often the desired effect. The degree varies between patients. Avoid driving or operating machinery until you understand how you respond.

Dizziness

Uncommon

Some patients experience mild dizziness, particularly at higher doses or when standing quickly.

Fatigue or morning grogginess

Uncommon

If taken in the evening, some patients notice mild grogginess the following morning. Dose timing adjustment usually resolves this.

Who is a good candidate?

Generally suitable for
  • Adults with anxiety or sleep difficulty seeking a non-benzodiazepine anxiolytic option
  • Those wanting anxiolytic support without the dependency risk of benzodiazepines
Not suitable for
  • Those who cannot tolerate any sedation
  • Patients using other central nervous system depressants without physician coordination

Contraindications

Your physician screens for these conditions before prescribing. Do not attempt to self-prescribe.

  • Pregnancy and breastfeeding
  • Situations requiring sustained full mental alertness
  • Concurrent use of other sedative medications without physician guidance

When to contact your physician

  • Nausea, vomiting, or digestive symptoms that are severe or do not ease within two weeks
  • Any chest pain, palpitations, or significant change in heart rate
  • Signs of allergic reaction: rash, hives, swelling of the face or throat, or difficulty breathing
  • Injection site reactions that worsen, spread, or do not resolve within 72 hours
  • Any new or worsening symptoms that concern you, regardless of whether they seem related to your protocol

If you are ever unsure, contact your physician. That is what they are there for.

Learn more

Have questions about DHH-B?

Message our team on WhatsApp. We typically reply within minutes.

Message us on WhatsApp
Consultation Form